To further assess the effect of Rac1 upstream signaling on RABV early infection, we employed EGFR inhibitor AG-1478, PI3K inhibitor Wortmannin, and Akt inhibitor AKT VIII after the optimal drug concentration evaluation (Fig. 7C through E). The gene discussed is RAC1; the disease is infection.